Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
journalStr:"ClinicalTrials.gov"
format_facet:"Elektronische Aufsätze"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22ClinicalTrials.gov%22&filter%5B%5D=format_facet%3A%22Elektronische+Aufs%C3%A4tze%22&lookfor=%22%2ALung+Neoplasms%22&type=Subject
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22ClinicalTrials.gov%22&filter%5B%5D=format_facet%3A%22Elektronische+Aufs%C3%A4tze%22&lookfor=%22%2ALung+Neoplasms%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=journalStr%3A%22ClinicalTrials.gov%22&filter%5B%5D=format_facet%3A%22Elektronische+Aufs%C3%A4tze%22&lookfor=%22%2ALung+Neoplasms%22&type=Subject
PubPharm (6.472)
1
A Study Comparing Alectinib With Crizotinib in Treatment-Naive Anaplastic Lymphoma Kinase-Positive Advanced Non-Small Cell Lung Cancer Participants : Randomized, Multicenter, Phase III, Open-Label Study of Alectinib Versus Crizotinib in Treatment-Naive Anaplastic Lymphoma Kinase-Positive Advanced Non-Small Cell Lung Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
2
Osimertinib and Gefitinib in EGFR Inhibitor naïve Advanced EGFR Mutant Lung Cancer : A Phase 1/2 Study of Osimertinib in Combination With Gefitinib in EGFR Inhibitor naïve Advanced EGFR Mutant Lung Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
3
Testing the Addition of a New Immunotherapy Drug, Atezolizumab (MPDL3280A), to the Usual Chemoradiation (CRT) Therapy Treatment for Limited Stage Small Cell Lung Cancer (LS-SCLC) : Limited Stage Small Cell Lung Cancer (LS-SCLC): A Phase III Randomized Study of Chemoradiation Versus Chemoradiation Plus Atezolizumab
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
4
Telaglenastat Hydrochloride and Osimertinib in Treating Patients With EGFR-Mutated Stage IV Non-small Cell Lung Cancer : A Phase Ib Study of Osimertinib (AZD9291) and Telaglenastat (CB-839) HCl in Patients With EGFR Mutant Non-Small Cell Lung Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
5
Testing the Addition of an Antibody to Standard Chemoradiation Followed by the Antibody for One Year to Standard Chemoradiation Followed by One Year of the Antibody in Patients With Unresectable Stage III Non-Small Cell Lung Cancer : Randomized Phase III Trial of MEDI4736 (Durvalumab) as Concurrent and Consolidative Therapy or Consolidative Therapy Alone for Unresectable Stage 3 NSCLC
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
6
Testing the Addition of the Pill Chemotherapy, Cabozantinib, to the Standard Immune Therapy Nivolumab Compared to Standard Chemotherapy for Non-small Cell Lung Cancer : A Randomized Phase II Trial of Cabozantinib and Cabozantinib Plus Nivolumab Versus Standard Chemotherapy in Patients With Previously Treated Non-Squamous NSCLC
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
7
National Cancer Institute "Cancer Moonshot Biobank" : Cancer Moonshot Biobank Research Protocol
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
8
Radiation Therapy to Relieve Symptoms in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) : PROMISE 006: A Phase I Study of up to 3 Cycles of Cyclical Hypofractionated Palliative Radiation (Quad Shot) for Lung Tumors in Patients With Stage IV Non-Small Cell Lung Cancer (NSCLC)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
9
Study to Access Safety of Durvalumab in Indian Adult Patients With Locally Advanced NSCLC : A Prospective, Multicenter, Phase-IV Clinical Trial to Assess Safety of Durvalumab in Indian Adult Patients With Locally Advanced, Unresectable Non-small Cell Lung Cancer (NSCLC)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
10
Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Lenvatinib (MK-7902/E7080) in Adults With Programmed Cell Death-Ligand 1 (PD-L1)-Positive Treatment-naïve Nonsmall Cell Lung Cancer (NSCLC) [MK-7902-007/E7080-G000-314/LEAP-007] - China Extension Study : A Phase 3, Randomized, Double-blind Trial of Pembrolizumab (MK-3475) With or Without Lenvatinib (E7080/MK-7902) in Participants With Treatment-naïve, Metastatic Nonsmall Cell Lung Cancer (NSCLC) Whose Tumors Have a Tumor Proportion Score (TPS) Greater Than or Equal to 1% (LEAP-007)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[648]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Zeitschrift: ClinicalTrials.gov
Filter aufheben
Medienart: E-Artikel
Medienart
6.472
Aufsätze
E-Artikel
6.472
E-Ressourcen
Zeitschriftentitel
ClinicalTrials.gov
Thema
6.472
610
6.468
Lung Neoplasms
5.186
Study Type: Interventional
3.637
Carcinoma, Non-Small-Cell Lung
2.333
Recruitment Status: Completed
1.980
Phase: Phase 2
1.583
Recruitment Status: Recruiting
1.222
Study Type: Observational
781
Phase: Phase 1
740
Small Cell Lung Carcinoma
702
Recruitment Status: Terminated
659
Phase: Phase 3
651
Medical Condition: Lung Cancer
638
Recruitment Status: Active, not recruiting
528
Recruitment Status: Unknown status
430
Carcinoma
400
Recruitment Status: Not yet recruiting
348
Medical Condition: Non-small Cell Lung Cancer
294
Phase: Phase 1, Phase 2
281
Medical Condition: Non Small Cell Lung Cancer
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
3.971
2020-
2.385
2010-2019
116
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
6.472
Englisch
Haven't found what you're looking for?
Wird geladen...